Literature DB >> 24167682

Ziprasidone for obsessive compulsive disorder in schizophrenia.

Daniela L Krause1, Judith Matz, Rebecca Schennach, Norbert Müller, Sandra Dehning.   

Abstract

Entities:  

Year:  2013        PMID： 24167682      PMCID： PMC3805396          DOI： 10.1177/2045125312467347

Source DB:  PubMed          Journal:  Ther Adv Psychopharmacol        ISSN： 2045-1253


× No keyword cloud information.
  4 in total

Review 1.  Relationships between obsessive-compulsive symptomatology and severity of psychosis in schizophrenia: a systematic review and meta-analysis.

Authors:  Ruth Cunill; Xavier Castells; Daphne Simeon
Journal:  J Clin Psychiatry       Date:  2008-12-02       Impact factor: 4.384

2.  Obsessive and compulsive symptoms in schizophrenia: a randomized controlled trial with fluvoxamine and neuroleptics.

Authors:  I Reznik; P Sirota
Journal:  J Clin Psychopharmacol       Date:  2000-08       Impact factor: 3.153

Review 3.  Obsessive-compulsive disorder in schizophrenia: clinical characteristics and treatment.

Authors:  Michael Poyurovsky; Abraham Weizman; Ronit Weizman
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

4.  Clozapine-induced obsessive-compulsive symptoms in schizophrenia: a critical review.

Authors:  Frederike Schirmbeck; Mathias Zink
Journal:  Curr Neuropharmacol       Date:  2012-03       Impact factor: 7.363
  4 in total
  1 in total

Review 1.  Management of obsessive-compulsive disorder comorbid with bipolar disorder.

Authors:  Firoz Kazhungil; E Mohandas
Journal:  Indian J Psychiatry       Date:  2016 Jul-Sep       Impact factor: 1.759
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.